CLA study finds reduction in body mass

[Guest guest]

CLA study finds

reduction in body mass

 

 

http://www.swansonvitamins.com/include/newsletter/emailRU_082704/RUa2_082704.html

 

 

The first study

to document the long-term safety and efficacy of Tonalin® brand

conjugated linoleic acid (CLA) found that the supplement reduces body

fat mass in overweight, but otherwise healthy adults by as much as nine

percent. The randomized, double-blind, placebo-controlled study was

conducted over a 12-month period without additional lifestyle or

dietary restrictions.

 

“The results of this first long-term study indicate that CLA, taken for

one year as a dietary supplement, safely improves the ratio of body fat

to lean tissue in overweight, but otherwise healthy adults,” said Dr.

Jean-Michel Gaullier of Scandinavian Clinical Research in Kjeller,

Norway. Study participants who took 3.4 g of CLA per day experienced a

significant reduction in their body fat mass compared to those in the

placebo group. The results confirm a trend observed in previous

short-term CLA studies.

 

In the study, 180 healthy men and women volunteers, ages 18-65, with a

body mass index indicating that they were overweight, were randomized

to receive softgel capsules containing either 3.4 g CLA-free fatty acid

(CLA-FFA), 3.4 g CLA-triacylglycerol or equivalent amounts of olive

oil, a placebo. Patients were studied for 12 months.

 

Weight, BMI, vital signs, and adverse events were recorded every three

months. Body composition and blood samples were analyzed at regular

intervals throughout the study, and participants were monitored

continuously for any signs of adverse events. The study concluded

“long-term supplementation with CLA-FFA or CLA-triacylglycerol reduces

BFM (body fat mass) in healthy overweight adults.”

 

American Journal of Clinical Nutrition 79(6):1118-1125,

2004

 

Go

to

swansonvitamins.com